Search Within

Martin Stuart Tallman

  1. "2015"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (25)
  3. Book Section (1)
Groups
  1. Adult Leukemia (64)
  2. Center for Hematologic Malignancies (64)
  3. Department of Medicine (64)
  4. Hematologic Malignancies, Division of (64)
  5. Executive Committee, Center for Hematologic Malignancies (21)
  6. GSK Faculty (21)

More Groups

People
  1. Ross Levine (18)
  2. Eytan Stein (10)
  3. Omar Abdel-Wahab (8)
  4. Sean Devlin (7)
  5. Dan Douer (6)
  6. Jae Park (6)

More People

Years
  1. 2015 (64)
Publications
  1. Blood (30)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Journal of Clinical Oncology (4)
  4. Haematologica (3)
  5. Leukemia (3)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. Elsevier Inc. (8)
  3. Nature Publishing Group (5)
  4. American Society of Clinical Oncology (4)
  5. Ferrata Storti Foundation (3)
  6. John Wiley & Sons (2)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated DNA/RNA profiling for somatic alterations in adult B-cell ALL
    Meeting Abstract

    Rapaport, F.; Patel, J.; He, J.; Brennan, T. A.; Nahas, M.; Balassubramanian, S.; Otto, G.; Lipson, D.; Stephens, P.; Miller, V. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Multi-center US intergroup study of intensive chemotherapy plus dasatinib followed by allogeneic stem cell transplant in patients with Philadelphia chromosome positive acute lymphoblastic leukemia younger than 60
    Meeting Abstract

    Ravandi, F.; Othus, M.; O'Brien, S.; Forman, S. J.; Ha, C. S.; Wong, J. Y. C.; Tallman, M. S.; Paietta, E.; Racevskis, J.; Uy, G. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse mechanisms of vemurafenib resistance in BRAF-mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Durham, B.; Chung, Y. R.; Scott, S.; Getta, B.; Kim, E.; Saven, A.; Stone, R. M.; Rai, K. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Tipifarnib as maintenance therapy in acute myeloid leukemia (AML) improves survival in a subgroup of patients with high risk disease. Results of the phase III intergroup trial E2902
    Meeting Abstract

    Luger, S.; Wang, V. X.; Paietta, E.; Ketterling, R. P.; Rybka, W.; Lazarus, H. M.; Litzow, M. R.; Rowe, J. M.; Larson, R. A.; Appelbaum, F. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous transplant, and not ATO alone, remains the preferred therapy for relapsed APL: A report from the CIBMTR, EBMT and two specialized centers
    Meeting Abstract

    Ganzel, C.; Mathews, V.; Alimoghaddam, K.; Ghavamzadeh, A.; Kuk, D.; Devlin, S.; Wang, H. L.; Weisdorf, D.; Douer, D.; Rowe, J. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • In Philadelphia-chromosome-negative acute lymphoblastic leukemia, late relapses are not uncommon, occur mostly in patients at standard risk and have a relatively favorable outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
    Meeting Abstract

    Ganzel, C.; Victoria, W. X.; Fielding, A. K.; Rowe, J. M.; Richards, S. M.; Buck, G.; Chopra, R.; Durrant, I. J.; Marks, D.; Franklin, I. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Hairy cell leukemia variant has similar survival to classical disease despite poorer responses to initial therapy: A 30-year experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Getta, B.; Woo, K. M.; Devlin, S.; Park, J. H.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly-diagnosed acute myeloid leukemia in older adults (age >= 60 years): A trial of the ECOG-ACRIN Cancer Research Group (E2906)
    Meeting Abstract

    Foran, J. M.; Sun, Z. X.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D.; Zhang, Y. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Very poor long-term survival, also in contemporary studies, of patients with AML who relapse after achieving a first complete remission: The ECOG-ACRIN Cancer Research Group experience
    Meeting Abstract

    Ganzel, C.; Cripe, L. D.; Sun, Z. X.; Fernandez, H. F.; Cassileth, P. A.; Douer, D.; Rowe, J. M.; Paietta, E.; O'Connell, M.; Wiernik, P. H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study
    Meeting Abstract

    DiNardo, C.; de Botton, S.; Pollyea, D. A.; Stein, E. M.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I. W.; Altman, J. K.; more...
    Blood (2015)

    Fulltext@MSK | Save